These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 18973252

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Balance in Parkinson's disease under static and dynamic conditions.
    Nardone A, Schieppati M.
    Mov Disord; 2006 Sep; 21(9):1515-20. PubMed ID: 16817196
    [Abstract] [Full Text] [Related]

  • 24. [Automatic motion analysis of gait in patients with Parkinson disease: effects of levodopa and visual stimulations].
    Azulay JP, Van Den Brand C, Mestre D, Blin O, Sangla I, Pouget J, Serratrice G.
    Rev Neurol (Paris); 1996 Feb; 152(2):128-34. PubMed ID: 8761620
    [Abstract] [Full Text] [Related]

  • 25. Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease.
    Ebersbach G, Edler D, Kaufhold O, Wissel J.
    Arch Phys Med Rehabil; 2008 Mar; 89(3):399-403. PubMed ID: 18295614
    [Abstract] [Full Text] [Related]

  • 26. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.
    Crenna P, Carpinella I, Lopiano L, Marzegan A, Rabuffetti M, Rizzone M, Lanotte M, Ferrarin M.
    Brain; 2008 Dec; 131(Pt 12):3410-20. PubMed ID: 18952669
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of sensory inputs and motor demands on the control of the centre of mass velocity during gait initiation in humans.
    Chastan N, Westby GW, du Montcel ST, Do MC, Chong RK, Agid Y, Welter ML.
    Neurosci Lett; 2010 Jan 29; 469(3):400-4. PubMed ID: 20026383
    [Abstract] [Full Text] [Related]

  • 29. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Wu T, Wang L, Chen Y, Zhao C, Li K, Chan P.
    Neurosci Lett; 2009 Aug 21; 460(1):6-10. PubMed ID: 19463891
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Gait analysis in patients with Parkinson's disease off dopaminergic therapy.
    Svehlík M, Zwick EB, Steinwender G, Linhart WE, Schwingenschuh P, Katschnig P, Ott E, Enzinger C.
    Arch Phys Med Rehabil; 2009 Nov 21; 90(11):1880-6. PubMed ID: 19887212
    [Abstract] [Full Text] [Related]

  • 32. The effects of levodopa use on diffusion coefficients in various brain regions in Parkinson's disease.
    Degirmenci B, Yaman M, Haktanir A, Albayrak R, Acar M, Caliskan G.
    Neurosci Lett; 2007 Apr 18; 416(3):294-8. PubMed ID: 17317000
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Maintaining balance against force perturbations: impaired mechanisms unresponsive to levodopa in Parkinson's disease.
    Di Giulio I, St George RJ, Kalliolia E, Peters AL, Limousin P, Day BL.
    J Neurophysiol; 2016 Aug 01; 116(2):493-502. PubMed ID: 27098030
    [Abstract] [Full Text] [Related]

  • 35. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K, Sibon I, Guehl D, Cuny E, Burbaud P, Allard M.
    Mov Disord; 2009 Oct 15; 24(13):1962-9. PubMed ID: 19672989
    [Abstract] [Full Text] [Related]

  • 36. [Gait disorders in Parkinson's disease: and pathophysiological approaches].
    Moreau C, Cantiniaux S, Delval A, Defebvre L, Azulay JP.
    Rev Neurol (Paris); 2010 Feb 15; 166(2):158-67. PubMed ID: 19616816
    [Abstract] [Full Text] [Related]

  • 37. Gait freezing in Parkinson's disease and the stride length sequence effect interaction.
    Chee R, Murphy A, Danoudis M, Georgiou-Karistianis N, Iansek R.
    Brain; 2009 Aug 15; 132(Pt 8):2151-60. PubMed ID: 19433440
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F, Nicoletti G, Cerasa A, Romeo N, Gallo O, Gioia MC, Arabia G, Pugliese P, Zappia M, Quattrone A.
    Brain Res Bull; 2007 Sep 14; 74(1-3):75-83. PubMed ID: 17683792
    [Abstract] [Full Text] [Related]

  • 40. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM.
    Med Sci Monit; 2005 Mar 14; 11(3):CR109-16. PubMed ID: 15735562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.